Big drug companies have little incentive to develop new antibiotics despite huge concerns about resistance to the drugs, according to a group of leading pharmacists.
The Royal Pharmaceutical Society (RPS) said the prospect of creating new drugs was "low due to the poor return on investment they provide".
The RPS said in its latest report that more must be done to support the discovery of new antibiotics.
It also called for the public to become more educated on the use of the medicines and better management of the drugs by healthcare workers.
More top news
A mother has been arrested on suspicion of attempted murder after her three young children were found with their throats cut.
Ex-Cuban leader Fidel Castro has broken his silence over Cuba and the United States' attempts to repair diplomatic relations.
David Cameron has pledged to reduce the annual benefits cap to £23,000 "within the first few days" of a Conservative election win.